Published by Global Banking & Finance Review®
Posted on July 15, 2025
3 min readLast updated: January 22, 2026
Add as preferred source on GoogleEuropean shares fell as financials and healthcare stocks dragged the market. Investors focus on US-EU trade deal and US inflation data.
By Sukriti Gupta, Sanchayaita Roy and Twesha Dikshit
(Reuters) -European shares ended lower on Tuesday, dragged down by heavyweight financial and healthcare stocks as investors awaited news on a potential U.S-EU trade deal while assessing the latest U.S. inflation data.
The pan-European STOXX 600 index closed down 0.4%. Most regional indexes declined, with Spain's IBEX falling 1.1%.
On Monday, the European Union accused the U.S. of resisting a trade deal and warned of countermeasures if no agreement is reached. U.S. President Donald Trump, meanwhile, said he was open to talks, adding that EU officials would visit the U.S. for trade negotiations.
"What we're seeing here is just a reflection of uncertainty surrounding EU-U.S. trade talks," said Fiona Cincotta, senior market analyst at City Index.
"That radio silence is just unnerving investors. They want to know that an improvement can be made on (the) 30% (tariff rate)."
The ZEW economic research institute said German investor morale rose more than expected in July, but economists warned that optimism would vanish without an EU-U.S. trade deal.
Across the Atlantic, big banks kicked off the earnings season, with investors closely assessing outlooks and tariff-related uncertainties. JPMorgan Chase raised its 2025 net interest income forecast and beat second-quarter profit estimates.
In the euro zone, the banking index slipped 1.1%. Germany's Commerzbank, Italy's Banco BPM and France's Societe Generale each fell more than 2%.
Healthcare also lagged, with Danish drugmaker Novo Nordisk sliding 2.3%.
Ericsson reported upbeat results but the Swedish telecom equipment maker's shares declined 7.7% after it warned of tariffs crimping its margin growth.
Barratt Redrow slid 9.4% after Britain's largest homebuilder reported that home completions missed expectations for fiscal 2025.
UK's B&M slumped 9.1% to a more-than-five-year low, after the discount retailer reported higher like-for-like revenue in its domestic business in the first quarter.
Curbing losses in the sector, the biggest supplier of computer chip-making equipment ASML climbed 2.7% ahead of its earnings on Wednesday.
News on Tuesday that U.S. consumer prices increased by the most in five months in June suggested tariffs were starting to fuel inflation, potentially keeping the Federal Reserve on the sidelines until September.
Among other stocks, Orsted gained 8.3% after Morgan Stanley raised its rating on the Danish offshore wind developer to "overweight" from "equal weight".
Accelleron rose 8.7% to a record high after the engine components maker increased its revenue forecast for 2025.
(Reporting by Sukriti Gupta, Sanchayaita Roy and Twesha Dikshit in Bengaluru; Editing by Rashmi Aich, Vijay Kishore and Richard Chang)
European shares fell primarily due to declines in heavyweight financial and healthcare stocks.
Investors are feeling uncertain about the EU-US trade talks, with the EU accusing the U.S. of resisting a deal.
The banking index in the euro zone slipped by 1.1%, with major banks like Commerzbank and Societe Generale each falling more than 2%.
The increase in U.S. consumer prices suggested that tariffs were starting to fuel inflation, potentially affecting the Federal Reserve's decisions.
Companies like Orsted and Accelleron saw gains of 8.3% and 8.7% respectively, while Barratt Redrow and B&M experienced declines of 9.4% and 9.1%.
Explore more articles in the Headlines category
